Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/30567518http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30567518http://www.w3.org/2000/01/rdf-schema#comment"

Background

Breast cancer is the most common malignancy in women affecting one out of eight females throughout their lives. Autotaxin (ATX) is upregulated in breast cancer which results in increased lysophosphatidic acid (LPA) formation within the tumor. This study's aim was to identify the role of different mammary cell populations within the ATX-LPA axis.

Methods

Epithelial-cell-adhesion-molecule-positive (EpCAM) and -negative cells from breast tumors, adipose-derived stem cells (ADSCs) of tumor-adjacent and tumor-distant mammary fat were isolated and compared to healthy ADSCs, mammary epithelial cells (HMECs), and mesenchymal cells (MES) of healthy mammary tissue (n = 4 each) and further to well-established breast (cancer) cell lines.

Results

mRNA expression analyses revealed that ADSCs and MES largely expressed LPA receptor 1 (LPAR1) while epithelial cells mainly expressed LPAR6. LPA 18:1 activated all the cell populations and cell lines by rise in cytosolic free calcium concentrations. MES and ADSCs expressed ATX whereas epithelial cells did not. ADSCs revealed the highest expression in ATX with a significant decline after adipogenic differentiation in healthy ADSCs, whereas ATX expression increased in ADSCs from tumor patients. Breast (cancer) cell lines did not express ATX. Transmigration of MES was stimulated by LPA whereas an inhibitory effect was observed in epithelial cells with no differences between tumors and healthy cells. Triple-negative breast cancer (TNBC) cell lines were also stimulated and the transmigration partly inhibited using the LPA receptor antagonist Ki16425.

Conclusions

We here show that each mammary cell population plays a different role in the ATX-LPA axis with ADSCs and adipocytes being the main source of ATX in tumor patients in our experimental setting. Inhibitors of this axis may therefore present a valuable target for pharmacological therapies."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.org/dc/terms/identifier"doi:10.1186/s12885-018-5166-z"xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Schmid R."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Wolf K."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Weigand A."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Strick R."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Strissel P.L."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Strauss S."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Fasching P.A."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Horch R.E."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Boos A.M."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Kremer A.E."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Rubner M."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/author"Robering J.W."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/name"BMC Cancer"xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/pages"1273"xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/title"ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro."xsd:string
http://purl.uniprot.org/citations/30567518http://purl.uniprot.org/core/volume"18"xsd:string
http://purl.uniprot.org/citations/30567518http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30567518
http://purl.uniprot.org/citations/30567518http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30567518
http://purl.uniprot.org/uniprot/#_B3KVQ5-mappedCitation-30567518http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30567518
http://purl.uniprot.org/uniprot/#_B4DJD3-mappedCitation-30567518http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30567518
http://purl.uniprot.org/uniprot/#_E7EUF1-mappedCitation-30567518http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30567518
▶